Identification of novel modulators of a schistosome transient receptor potential channel targeted by praziquantel.
Given the worldwide burden of neglected tropical diseases, there is ongoing need to develop novel anthelmintic agents to strengthen the pipeline of drugs to combat these burdensome infections. Many diseases caused by parasitic flatworms are treated using the anthelmintic drug praziquantel (PZQ), emp...
Guardado en:
Autores principales: | Evgeny G Chulkov, Emery Smith, Claudia M Rohr, Nawal A Yahya, Sang-Kyu Park, Louis Scampavia, Timothy P Spicer, Jonathan S Marchant |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/abaa115946af4e45b4a03469ea0cec2b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of novel modulators of a schistosome transient receptor potential channel targeted by praziquantel
por: Evgeny G. Chulkov, et al.
Publicado: (2021) -
A novel biological activity of praziquantel requiring voltage-operated Ca2+ channel beta subunits: subversion of flatworm regenerative polarity.
por: Taisaku Nogi, et al.
Publicado: (2009) -
Schistosome infection in Senegal is associated with different spatial extents of risk and ecological drivers for Schistosoma haematobium and S. mansoni.
por: Isabel J Jones, et al.
Publicado: (2021) -
Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials.
por: Dimitrios K Matthaiou, et al.
Publicado: (2008) -
Non-invasive sampling of schistosomes from humans requires correcting for family structure.
por: Michelle L Steinauer, et al.
Publicado: (2013)